1. Contractors
  2. Spring Mill Pharma Incorporated

Spring Mill Pharma Incorporated

Federal contractor · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Spring Mill Pharma has 1 federal contract of $100,000 or more active since October 2023, with $25M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
1 since FY2024$25,044,893 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
National Institutes of Health$25M on 1 contract
UEI
UWZNAK5HJLN7Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
To Advance a Novel Beta-Lactamase Inhibitor of Penicillin Binding Proteins Targeting Mdr-Acinetobacter Baumannii.National Institutes of Health · 75N93020C00016$25,044,893Jan 31, 2028in 14 monthsPA

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
National Institutes of Health1 contract$25,044,893

Where the work is

Place of workAmount
Pennsylvania1 contract$25,044,893

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.

Get new notices like Spring Mill Pharma's work

New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy